DE2634904A1 - Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2634904A1
DE2634904A1 DE19762634904 DE2634904A DE2634904A1 DE 2634904 A1 DE2634904 A1 DE 2634904A1 DE 19762634904 DE19762634904 DE 19762634904 DE 2634904 A DE2634904 A DE 2634904A DE 2634904 A1 DE2634904 A1 DE 2634904A1
Authority
DE
Germany
Prior art keywords
water
strain
mycobacteria
acid
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762634904
Other languages
German (de)
English (en)
Inventor
Pierre Jolles
Geb Samour Daniele Migliore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of DE2634904A1 publication Critical patent/DE2634904A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19762634904 1975-08-05 1976-08-03 Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel Pending DE2634904A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Publications (1)

Publication Number Publication Date
DE2634904A1 true DE2634904A1 (de) 1977-02-10

Family

ID=9158793

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762634904 Pending DE2634904A1 (de) 1975-08-05 1976-08-03 Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (11)

Country Link
US (1) US4110434A (US20110009641A1-20110113-C00185.png)
JP (1) JPS5234917A (US20110009641A1-20110113-C00185.png)
BE (1) BE844672A (US20110009641A1-20110113-C00185.png)
DE (1) DE2634904A1 (US20110009641A1-20110113-C00185.png)
DK (1) DK352276A (US20110009641A1-20110113-C00185.png)
FR (1) FR2320107A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1525763A (US20110009641A1-20110113-C00185.png)
IL (1) IL50187A0 (US20110009641A1-20110113-C00185.png)
LU (1) LU75522A1 (US20110009641A1-20110113-C00185.png)
NL (1) NL7608680A (US20110009641A1-20110113-C00185.png)
SE (1) SE7608640L (US20110009641A1-20110113-C00185.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS59116681A (ja) * 1982-12-23 1984-07-05 セイコーインスツルメンツ株式会社 液晶表示装置
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
EP0681479B1 (en) * 1993-01-29 1999-04-28 Vetrepharm, Inc. Immunotherapeutic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2816C (US20110009641A1-20110113-C00185.png) *
US3429868A (en) * 1956-03-12 1969-02-25 Kiyoshi Kominato Method of preparing a series of prosthetic groups and coenzymes of a new redox-enzyme which are present in plants,animals,or foods and have vitamin-like activity
NL7308450A (US20110009641A1-20110113-C00185.png) * 1972-06-20 1973-12-27
US3941762A (en) * 1973-05-07 1976-03-02 E. R. Squibb & Sons, Inc. O-acyl derivatives of antibiotic EM-49
FR2269961B1 (US20110009641A1-20110113-C00185.png) * 1974-05-06 1978-03-24 Anvar
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties

Also Published As

Publication number Publication date
US4110434A (en) 1978-08-29
FR2320107A1 (fr) 1977-03-04
SE7608640L (sv) 1977-02-06
LU75522A1 (US20110009641A1-20110113-C00185.png) 1977-03-25
NL7608680A (nl) 1977-02-08
DK352276A (da) 1977-02-06
FR2320107B1 (US20110009641A1-20110113-C00185.png) 1980-01-11
JPS5234917A (en) 1977-03-17
IL50187A0 (en) 1976-10-31
GB1525763A (en) 1978-09-20
BE844672A (fr) 1976-11-16

Similar Documents

Publication Publication Date Title
DE3921416C2 (de) Modifizierte Lipopolysaccharide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE2638762A1 (de) Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3407823C2 (US20110009641A1-20110113-C00185.png)
DE2659808C3 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE3448151C2 (US20110009641A1-20110113-C00185.png)
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2610504A1 (de) Verfahren zur herstellung einer von pseudomonas aeruginosa stammenden komponente aus zucker, lipoid und protein, mit antitumor- und interferon bildenden eigenschaften
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
DE2634904A1 (de) Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3850257T2 (de) Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.
DE3024355A1 (de) Neue dipeptide, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3783268T2 (de) Immunomodulatoren, hergestellt durch halbsynthese eines bakteriellen polysaccharides, extrahiert aus einer mutierten nicht-capsulierten stamm von klebsiella pneumoniae.
DE69810024T2 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
DE1617397B2 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DE1915687A1 (de) Verfahren zur Herstellung von Polysacchariden mit Antitumorwirkung
DE69420704T2 (de) Bakterien vom alteromonastyp, durch diese bakterien hergestellte polysaccharide, in diesen polysacchariden enthaltene ose und ihre anwendungen
DE2519937A1 (de) Acetylierte extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2828933A1 (de) 3- eckige klammer auf (s)-1'-phenylaethylamino eckige klammer zu -propylaminobleomycin, verfahren zu seiner herstellung und diese verbindung enthaltendes arzneimittel
DE1208449B (de) Verfahren zur Herstellung des Antibiotikums Ussamycin
DE3873139T2 (de) Derivat von d.25, verfahren zur herstellung, verwendung als immunostimulierendes mittel und pharmazeutische zusammensetzungen, welche diese enthalten.
DE1962795A1 (de) Chemisch modifiziertes Endotoxin-Immunisierungmittel
DE2539044A1 (de) Wasserloesliche extrakte von mycobakterien
DE2856410C2 (de) Heptapeptide K 582 M-A und K 582 M-B, Verfahren zu ihrer Herstellung und diese Heptapeptide enthaltende Arzneimittel

Legal Events

Date Code Title Description
OHN Withdrawal